About Pegfilgrastim
Class: | Hematopoietic agent, Granulocyte colony-stimulating factor (G-CSF)
Use: | Used to reduce the incidence of infection, as manifested by febrile neutropenia, in patients receiving myelosuppressive chemotherapy for malignancies.
Adult dose: | 6 mg administered as a single subcutaneous injection once per chemotherapy cycle, typically given 24 hours after chemotherapy.
Pediatric dose: | 6 mg administered as a single subcutaneous injection once per chemotherapy cycle for pediatric patien
Drug Class
Hematopoietic agent, Granulocyte colony-stimulating factor (G-CSF)
Uses & Indications
Used to reduce the incidence of infection, as manifested by febrile neutropenia, in patients receiving myelosuppressive chemotherapy for malignancies.
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. Can be kept at room temperature (up to 25°C or 77°F) for up to 48 hours before use.
Manufacturer & Packaging
Manufacturer: Pfizer Europe MA EEIG [Bruxells;BELGIUM], Belgium
Package Size
1 Pre-filled Syringe [0.6 mL]
Price & Supplier
Price in UAE: AED 1927.50
Dosage Information
Adult Dose
6 mg administered as a single subcutaneous injection once per chemotherapy cycle, typically given 24 hours after chemotherapy.
Pediatric Dose
6 mg administered as a single subcutaneous injection once per chemotherapy cycle for pediatric patients 1 year and older; dosing may vary based on specific clinical circumstances.
Side Effects
Common side effects include bone pain, fatigue, headache, nausea, and injection site reactions (e.g., redness, swelling).
Contraindications & Precautions
Hypersensitivity to pegfilgrastim or any component of the formulation; caution in patients with sickle cell disease or those receiving chemotherapy that may cause severe bone marrow suppression.
Important Warnings
Risk of splenic rupture; may cause acute respiratory distress syndrome (ARDS); monitor for signs of allergic reactions; use with caution in patients with pre-existing conditions that may predispose them to complications.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.